Exploratory Analysis of Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma Who Have Failed Prior PD−1/PD-L1 Checkpoint Blockade

SIMPLE SUMMARY: Programmed cell death protein 1 (PD−1)/PD-ligand 1 (PD-L1) blockade is becoming a novel therapeutic option for a hepatocellular carcinoma. In this work, we evaluated efficacy and safety of lenvatinib following failure of PD-1/PD-L1 blockade. The median progression-free survival was 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Aoki, Tomoko, Kudo, Masatoshi, Ueshima, Kazuomi, Morita, Masahiro, Chishina, Hirokazu, Takita, Masahiro, Hagiwara, Satoru, Ida, Hiroshi, Minami, Yasunori, Tsurusaki, Masakatsu, Nishida, Naoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590172/
https://www.ncbi.nlm.nih.gov/pubmed/33092011
http://dx.doi.org/10.3390/cancers12103048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590172/
https://www.ncbi.nlm.nih.gov/pubmed/33092011
http://dx.doi.org/10.3390/cancers12103048

Ejemplares similares